Characteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer

Conditions: DILI Interventions: Drug: Ribociclib, palbociclib, abemaciclib Sponsors: University of Milano Bicocca Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials